[
  {
    "date": "2022-12-30",
    "symbol": "ELOX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ELOX",
    "entityregistrantname": "ELOXX PHARMACEUTICALS, INC.",
    "entitycentralindexkey": 1035354,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "001-31326",
    "entitytaxidentificationnumber": "84-1368850",
    "entityaddressaddressline1": "480 Arsenal Way",
    "entityaddresscityortown": "Watertown",
    "entityaddressstateorprovince": "Massachusetts",
    "entityaddresspostalzipcode": 2472,
    "cityareacode": 781,
    "localphonenumber": "577-5300",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "true",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "Delaware",
    "security12btitle": "Common Stock, $0.01 par value",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "auditorname": "Baker Tilly US, LLP",
    "auditorlocation": "Tewksbury, Massachusetts",
    "auditorfirmid": 23,
    "cashandcashequivalentsatcarryingvalue": 19207000,
    "restrictedcashcurrent": 261000,
    "prepaidexpenseandotherassetscurrent": 661000,
    "assetscurrent": 20129000,
    "propertyplantandequipmentnet": 169000,
    "operatingleaserightofuseasset": 825000,
    "assets": 21123000,
    "accountspayablecurrent": 3020000,
    "accruedliabilitiescurrent": 2799000,
    "longtermdebtcurrent": 3980000,
    "duetoaffiliatecurrent": 45000,
    "operatingleaseliabilitycurrent": 712000,
    "derivativeliabilitiescurrent": 45000,
    "liabilitiescurrent": 23091000,
    "longtermdebtnoncurrent": 8557000,
    "operatingleaseliabilitynoncurrent": 135000,
    "liabilities": 31783000,
    "commonstockvalue": 22000,
    "additionalpaidincapitalcommonstock": 263706000,
    "retainedearningsaccumulateddeficit": -274388000,
    "stockholdersequity": -274388000,
    "liabilitiesandstockholdersequity": 21123000,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 23727000,
    "generalandadministrativeexpense": 10692000,
    "operatingexpenses": 34419000,
    "operatingincomeloss": -34419000,
    "othernonoperatingincomeexpense": -1646000,
    "netincomeloss": -36065000,
    "earningspersharebasic": -16.65,
    "earningspersharediluted": -16.65,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "restrictedstockvestedduringperiodshares": 157,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 3021000,
    "retirementoftreasurystock": 2190000,
    "retirementoftreasurystockshares": 10535,
    "effectofreversestocksplit": -49,
    "profitloss": -36065000,
    "sharebasedcompensation": 3021000,
    "depreciation": 77000,
    "impairmentoflonglivedassetsheldforuse": 36000,
    "operatingleaserightofuseassetamortizationexpense": 618000,
    "amortizationofdebtdiscountpremium": 541000,
    "changeinfairvalueofderivativeliabilities": 45000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -252000,
    "increasedecreaseinaccountspayable": 1641000,
    "increasedecreaseinaccruedliabilities": -1397000,
    "increasedecreaseinoperatingleaseliabilities": -614000,
    "netcashprovidedbyusedinoperatingactivities": -31845000,
    "paymentstoacquirepropertyplantandequipment": 66000,
    "netcashprovidedbyusedininvestingactivities": -66000,
    "proceedsfromadvancesfromcollaborationpartners": 8812000,
    "netcashprovidedbyusedinfinancingactivities": 8812000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -23099000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 19468000,
    "restrictedcashandcashequivalents": 261000,
    "interestpaidnet": 1365000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 64000,
    "longtermdebt": 11718000,
    "minimumqualifiedcashbalance": 10000000,
    "cashandcashequivalentandavailableforsaledebtsecurities": 19200000,
    "effectivecashbalance": 10000000,
    "additionalcashandcashequivalentandavailableforsaledebtsecurities": 10000000,
    "otheraccruedliabilitiescurrent": 134000,
    "propertyplantandequipmentusefullife": 5,
    "propertyplantandequipmentusefullifedescription": "Over the shorter of the expected remaining lease term or estimated useful life",
    "prepaidresearchanddevelopmentcurrent": 366000,
    "prepaidinsurance": 93000,
    "otherprepaidexpensecurrent": 202000,
    "propertyplantandequipmentgross": 349000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 180000,
    "goodwillimpairmentloss": 36000,
    "accruedresearchanddevelopmentexpensecurrent": 1544000,
    "employeerelatedliabilitiescurrent": 750000,
    "accruedprofessionalfeescurrent": 225000,
    "accruedinterestondebt": 146000,
    "operatingleasecost": 700000,
    "operatingleaseweightedaverageincrementalborrowingrate": 0.054000000000000006,
    "operatingleaseweightedaverageremainingleaseterm1": 1.18,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 740000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 134000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2000,
    "lesseeoperatingleaseliabilitypaymentsdue": 876000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 29000,
    "operatingleaseliability": 847000,
    "longtermdebtpercentagebearingvariableinterestrate": 0.1375,
    "debtinstrumentprepaymentfeepercentage": 0.02,
    "debtinstrumentfinalpaymentfeepercentage": 0.01,
    "debtinstrumentcarryingamount": 12500000,
    "debtinstrumentunamortizeddiscount": 200000,
    "interestexpensedebt": 1900000,
    "debtinstrumentinterestrateeffectivepercentage": 0.195,
    "longtermdebtmaturitiesfinalfeedue": 819000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 440.8,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 4204000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 6101000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 2195000,
    "aggregateamountofmilestonepayment": 6100000,
    "remainingamountofawardpayableuponachievementcertainclinicaldevelopmentmilestones": 7400000,
    "royaltiespercentageofnetsalesbasedonactualamountoffunding": 0.06,
    "percentageofconsiderationreceivedfordispositionevent": 0.2,
    "percentageofsaleorlicenseevent": 0.1,
    "numberoftimesamountoffundsreceived": 8,
    "proceedsfromresearchanddevelopmentgrants": 2600000,
    "royaltypaymentpercentageonnetsales": 0.03,
    "embeddedderivativegainlossonembeddedderivativenet": 45000,
    "maximumrepaymentpercentageofgrantsreceivedfromofficeofchiefscientist": 1,
    "contingentliabilityrelatedtograntsreceivedroyaltiespayableincludingaccruedliborinterest": 2800000,
    "clinicalandregulatorymilestonepaymentsreceived": 3600000,
    "percentageofobligatedtoremitharvardfees": 0.3,
    "patentexpensesduetoharvard": 200000,
    "relatedpartytransactionpercentageofexpenses": 0.05,
    "classofwarrantorrightoutstanding": 1021,
    "classofwarrantorrightforfeited": -7076,
    "classofwarrantorrightexercisable": 1021,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 59320,
    "classofwarrantorrightforfeitedinperiodweightedaverageexerciseprice": 133.91,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 367.39,
    "classofwarrantorrightexercisableinperiodweightedaverageexerciseprice": 440.8,
    "classofwarrantorrightexpirationperiod": 6.08,
    "classofwarrantorrightexercisableexpirationperiod": 6.08,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodcontractuallife": "ten-year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexercisableperiodofvestedoptions": "three months",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 86112,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 17.88,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 5300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 12.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 249403,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 81809,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 105.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 214.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 6.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.8200000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0184,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0396,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionscontractualterm": 10,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 157,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 600.8,
    "allocatedsharebasedcompensationexpense": 3021000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -22991000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -13074000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -36065000,
    "deferredtaxassetsvaluationallowance": 79977000,
    "valuationallowancedeferredtaxassetchangeinamount": 8400000,
    "operatinglosscarryforwards": 101200000,
    "netoperatinglosscarryforwardexpirationyear": 2037,
    "operatinglosscarryforwardsnotsubjecttoexpiration": 84100000,
    "netoperatinglosscarryforwardseligibletooffsettaxableincomemaximum": 0.8,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 8100000,
    "federalresearchcreditscarryforwardsexpirationyear": 2041,
    "deferredtaxassetsoperatinglosscarryforwards": 58334000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1831000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 170000,
    "deferredtaxassetstaxcreditcarryforwards": 8226000,
    "deferredtaxassetsinprocessresearchanddevelopment": 11184000,
    "deferredtaxassetsoperatingleaserightofuseassets": 197000,
    "deferredtaxassetsoperatingleaseliabilities": 203000,
    "deferredtaxassetsother": 226000,
    "deferredtaxassetsgross": 79977000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.022000000000000002,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.07400000000000001,
    "effectiveincometaxratereconciliationtaxcredits": 0.066,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": 0.01,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.23399999999999999,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 250424,
    "interestandotherincome": 274000,
    "interestexpenseother": 1949000,
    "foreigncurrencytransactiongainlossbeforetax": -3000,
    "researchanddevelopmenttaxcreditincome": -77000,
    "numberofoperatingsegments": 1,
    "numberofgeographicregions": 3,
    "cashandcashequivalentsfairvaluedisclosure": 18737000,
    "embeddedderivativefairvalueofembeddedderivativeliability": 45000
  },
  {
    "date": "2021-12-30",
    "symbol": "ELOX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ELOX",
    "entityregistrantname": "ELOXX PHARMACEUTICALS, INC.",
    "entitycentralindexkey": 1035354,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "001-31326",
    "entitytaxidentificationnumber": "84-1368850",
    "entityaddressaddressline1": "480 Arsenal Way",
    "entityaddresscityortown": "Watertown",
    "entityaddressstateorprovince": "Massachusetts",
    "entityaddresspostalzipcode": 2472,
    "cityareacode": 781,
    "localphonenumber": "577-5300",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "Delaware",
    "security12btitle": "Common Stock, $0.01 par value",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "auditorname": "Deloitte & Touche LLP",
    "auditorlocation": "Boston, Massachusetts",
    "auditorfirmid": 34,
    "cashandcashequivalentsatcarryingvalue": 42268000,
    "restrictedcashcurrent": 299000,
    "prepaidexpenseandotherassetscurrent": 913000,
    "assetscurrent": 43480000,
    "propertyplantandequipmentnet": 216000,
    "operatingleaserightofuseasset": 1443000,
    "assets": 45139000,
    "accountspayablecurrent": 1379000,
    "accruedliabilitiescurrent": 4196000,
    "duetoaffiliatecurrent": 300000,
    "operatingleaseliabilitycurrent": 657000,
    "liabilitiescurrent": 9955000,
    "longtermdebtnoncurrent": 11996000,
    "operatingleaseliabilitynoncurrent": 804000,
    "liabilities": 22755000,
    "commonstockvalue": 871000,
    "treasurystockcommonvalue": 2190000,
    "additionalpaidincapitalcommonstock": 262026000,
    "retainedearningsaccumulateddeficit": -238323000,
    "stockholdersequity": -238323000,
    "liabilitiesandstockholdersequity": 45139000,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": -421366,
    "treasurystockcommonshares": 421366,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 22899000,
    "generalandadministrativeexpense": 20449000,
    "researchanddevelopmentinprocess": 22670000,
    "operatingexpenses": 66018000,
    "operatingincomeloss": -66018000,
    "othernonoperatingincomeexpense": -709000,
    "netincomeloss": -66727000,
    "earningspersharebasicanddiluted": -0.95,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "comprehensiveincomenetoftax": -66727000,
    "stockissuedduringperiodvaluestockoptionsexercised": 23000,
    "stockissuedduringperiodsharesstockoptionsexercised": 23491,
    "stockissuedduringperiodvalueacquisitions": 22335000,
    "stockissuedduringperiodsharesacquisitions": "null",
    "stockissuedduringperiodvaluenewissues": 47718000,
    "stockissuedduringperiodsharesnewissues": "null",
    "restrictedstockvestedduringperiodvalue": -362000,
    "restrictedstockvestedduringperiodshares": -227631,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 9167000,
    "profitloss": -66727000,
    "sharebasedcompensation": 9167000,
    "depreciation": 114000,
    "operatingleaserightofuseassetamortization": 846000,
    "amortizationofdebtdiscountpremium": 420000,
    "gainlossonsaleofpropertyplantequipment": -84000,
    "gainonextinguishmentofpaycheckprotectionprogramdebt": 808000,
    "lossonextinguishmentoftermdebt": 268000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -582000,
    "increasedecreaseinaccountspayable": -320000,
    "increasedecreaseinaccruedliabilities": 535000,
    "paymentsformergerrelatedcosts": 1000000,
    "increasedecreaseinoperatingleaseliabilities": -829000,
    "netcashprovidedbyusedinoperatingactivities": -35001000,
    "cashacquiredfromacquisition": 2145000,
    "paymentstoacquirepropertyplantandequipment": 89000,
    "netcashprovidedbyusedininvestingactivities": 2056000,
    "proceedsfromissuanceofcommonstock": 47718000,
    "proceedsfromissuanceoflongtermdebt": 11874000,
    "repaymentsofnotespayable": 11383000,
    "proceedsfromstockoptionsexercised": 23000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 362000,
    "proceedsfromadvancesfromcollaborationpartners": 2918000,
    "netcashprovidedbyusedinfinancingactivities": 50788000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 17843000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 42567000,
    "restrictedcashandcashequivalents": 299000,
    "interestpaidnet": 728000,
    "longtermdebt": 11177000,
    "minimumqualifiedcashbalance": 10000000,
    "cashandcashequivalentandavailableforsaledebtsecurities": 42300000,
    "otheraccruedliabilitiescurrent": 141000,
    "propertyplantandequipmentusefullife": 5,
    "propertyplantandequipmentusefullifedescription": "Over the shorter of the expected remaining lease term or estimated useful life",
    "prepaidresearchanddevelopmentcurrent": 413000,
    "prepaidinsurance": 123000,
    "otherprepaidexpensecurrent": 377000,
    "propertyplantandequipmentgross": 387000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 171000,
    "accruedresearchanddevelopmentexpensecurrent": 1849000,
    "employeerelatedliabilitiescurrent": 1615000,
    "accruedprofessionalfeescurrent": 489000,
    "accruedinterestondebt": 102000,
    "operatingleasecost": 1100000,
    "operatingleaseweightedaverageincrementalborrowingrate": 0.08,
    "operatingleaseweightedaverageremainingleaseterm1": 2.13,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 715000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 704000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 125000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 2000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1546000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 85000,
    "operatingleaseliability": 1461000,
    "debtinstrumentinterestrateterms": "Any outstanding principal on the Term Loan Advances will accrue interest at a floating rate equal to the greater of (i) 9.50% per annum and (ii) the sum of 6.25% plus the prime rate, as published in The Wall Street Journal. On September 30, 2021, the interest rate was 9.5%. Interest payments are payable monthly following the funding of a Term Loan Advance.",
    "debtinstrumentpaymentterms": "The Company will be required to make principal payments on the outstanding balance of the Term Loan Advances commencing on April 1, 2023 (the “Term Loan Amortization Date”) in 36 equal monthly instalments, plus interest; provided that if the Company has achieved the milestones described above, then the Term Loan Amortization Date will be automatically extended to October 1, 2023 or April 1, 2024, as applicable.",
    "debtinstrumentbasisspreadonvariablerate1": 0.0625,
    "debtinstrumentfrequencyofperiodicpayment": "monthly",
    "debtinstrumentrepaymentnumberofinstallments": 36,
    "debtinstrumentdateoffirstrequiredpayment1": "April 1, 2023",
    "debtinstrumentmaturitydate": "April 1, 2025",
    "debtinstrumentprincipalamountpercentage": 0.0655,
    "debtinstrumentprepaymentfeepercentage": 0.02,
    "debtinstrumentfinalpaymentfeepercentage": 0.01,
    "debtinstrumentcarryingamount": 12500000,
    "debtinstrumentunamortizeddiscount": 1323000,
    "interestexpensedebt": 900000,
    "debtinstrumentinterestrateeffectivepercentage": 0.1499,
    "longtermdebtmaturitiesfinalfeedue": -819000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 4.31,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 4204000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 6101000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 2195000,
    "aggregateamountofmilestonepayment": 6100000,
    "royaltypaymentpercentageonnetsales": 0.03,
    "maximumrepaymentpercentageofgrantsreceivedfromofficeofchiefscientist": 1,
    "contingentliabilityrelatedtograntsreceivedroyaltiespayableincludingaccruedliborinterest": 2800000,
    "clinicalandregulatorymilestonepaymentsreceived": 3600000,
    "percentageofobligatedtoremitharvardfees": 0.3,
    "relatedpartytransactionpercentageofexpenses": 0.05,
    "classofwarrantorrightoutstanding": 323892,
    "classofwarrantorrightexercisable": 323892,
    "classofwarrantorrightexercisableinperiodweightedaverageexerciseprice": 4.31,
    "classofwarrantorrightexpirationperiod": "P1Y8M26D",
    "classofwarrantorrightexercisableexpirationperiod": "P1Y8M26D",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodcontractuallife": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexercisableperiodofvestedoptions": "three months",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 542679,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 7800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 0.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.56,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.24,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.05,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 5.44,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 11.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y2M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P2Y9M14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 254223,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 254223,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0087,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 1.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionscontractualterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 6263,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 766767,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 119374,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 15.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 3.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 4.05,
    "allocatedsharebasedcompensationexpense": 9167000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -47849000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 17000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -66727000,
    "deferredtaxassetsvaluationallowance": 71589000,
    "valuationallowancedeferredtaxassetchangeinamount": 19000000,
    "operatinglosscarryforwards": 99300000,
    "netoperatinglosscarryforwardexpirationyear": 2037,
    "operatinglosscarryforwardsnotsubjecttoexpiration": 82500000,
    "netoperatinglosscarryforwardseligibletooffsettaxableincomemaximum": 0.8,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 5900000,
    "federalresearchcreditscarryforwardsexpirationyear": 2041,
    "deferredtaxassetsoperatinglosscarryforwards": 57716000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 3143000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 337000,
    "deferredtaxassetstaxcreditcarryforwards": 6009000,
    "deferredtaxassetsinprocessresearchanddevelopment": 3988000,
    "deferredtaxassetsoperatingleaserightofuseassets": 338000,
    "deferredtaxassetsoperatingleaseliabilities": 363000,
    "deferredtaxassetsother": 371000,
    "deferredtaxassetsgross": 71589000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.01,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.073,
    "effectiveincometaxratereconciliationtaxcredits": 0.035,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": 0.006,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.188,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "interestandotherincome": 8000,
    "foreigncurrencytransactiongainlossbeforetax": 2000,
    "interestexpenseother": 1259000,
    "gainonextinguishmentofdebt": 808000,
    "lossesonextinguishmentofdebt": 268000,
    "numberofoperatingsegments": 1,
    "numberofgeographicregions": 3,
    "cashandcashequivalentsfairvaluedisclosure": 42268000,
    "cashandcashequivalentandavailableforsaledebtsecuritiesamortizedcost": 42268000
  },
  {
    "date": "2020-12-30",
    "symbol": "ELOX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2020",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ELOX",
    "entityregistrantname": "ELOXX PHARMACEUTICALS, INC.",
    "entitycentralindexkey": 1035354,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "001-31326",
    "entitytaxidentificationnumber": "84-1368850",
    "entityaddressaddressline1": "950 Winter Street",
    "entityaddresscityortown": "Waltham",
    "entityaddressstateorprovince": "Massachusetts",
    "entityaddresspostalzipcode": 2451,
    "cityareacode": 781,
    "localphonenumber": "577-5300",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "Delaware",
    "security12btitle": "Common Stock, $0.01 par value",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "cashandcashequivalentsatcarryingvalue": 24668000,
    "restrictedcashcurrent": 56000,
    "prepaidexpenseandotherassetscurrent": 1169000,
    "assetscurrent": 25893000,
    "propertyplantandequipmentnet": 133000,
    "operatingleaserightofuseasset": 421000,
    "otherassetsnoncurrent": 30000,
    "assets": 26477000,
    "accountspayablecurrent": 481000,
    "accruedliabilitiescurrent": 2886000,
    "longtermdebtcurrent": 5239000,
    "duetoaffiliatecurrent": 805000,
    "operatingleaseliabilitycurrent": 389000,
    "taxespayablecurrent": 38000,
    "liabilitiescurrent": 9838000,
    "longtermdebtnoncurrent": 6376000,
    "operatingleaseliabilitynoncurrent": 33000,
    "liabilities": 16247000,
    "commonstockvalue": 404000,
    "treasurystockcommonvalue": 1828000,
    "additionalpaidincapitalcommonstock": 183250000,
    "retainedearningsaccumulateddeficit": -171596000,
    "stockholdersequity": -171596000,
    "liabilitiesandstockholdersequity": 26477000,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": -193735,
    "treasurystockcommonshares": 193735,
    "researchanddevelopmentexpense": 14590000,
    "generalandadministrativeexpense": 14847000,
    "restructuringchargesincludesstockbasedcompensation": 4018000,
    "operatingexpenses": 33455000,
    "operatingincomeloss": -33455000,
    "othernonoperatingincomeexpense": -1122000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -34577000,
    "netincomeloss": -34577000,
    "earningspersharebasicanddiluted": -0.86,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "othercomprehensiveincomeavailableforsalesecuritiesadjustmentnetoftaxportionattributabletoparent": -18000,
    "comprehensiveincomenetoftax": -34595000,
    "stockissuedduringperiodvaluestockoptionsexercised": 71000,
    "stockissuedduringperiodsharesstockoptionsexercised": 17210,
    "restrictedstockvestedduringperiodvalue": -125000,
    "restrictedstockvestedduringperiodshares": -38029,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 8666000,
    "profitloss": -34577000,
    "sharebasedcompensation": 8666000,
    "depreciation": 68000,
    "operatingleaserightofuseassetamortization": 503000,
    "amortizationofdebtdiscountpremium": 563000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -15000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -262000,
    "increasedecreaseinaccountspayable": -1390000,
    "increasedecreaseinaccruedliabilities": -1769000,
    "increasedecreaseinoperatingleaseliabilities": -502000,
    "increasedecreaseinaccruedtaxespayable": -5000,
    "netcashprovidedbyusedinoperatingactivities": -28166000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 33750000,
    "paymentsforproceedsfromlongterminvestments": -42000,
    "netcashprovidedbyusedininvestingactivities": 33792000,
    "proceedsfromissuanceoflongtermdebt": 797000,
    "repaymentsofnotespayable": 4583000,
    "proceedsfromstockoptionsexercised": 71000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 125000,
    "proceedsfromadvancesfromcollaborationpartner": 402000,
    "netcashprovidedbyusedinfinancingactivities": -3438000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 2188000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 24724000,
    "restrictedcashandcashequivalents": 56000,
    "interestpaidnet": 828000,
    "incometaxespaidnet": 5000,
    "numberofrareandultrararediseaseduetoprematurestoppageofcodons": 1800,
    "cashandcashequivalentandavailableforsaledebtsecurities": 24700000,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2020",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "propertyplantandequipmentusefullife": 5,
    "propertyplantandequipmentusefullifedescription": "Over the shorter of the expected remaining lease term or estimated useful life",
    "prepaidresearchanddevelopmentcurrent": 631000,
    "prepaidinsurance": 170000,
    "otherprepaidexpensecurrent": 368000,
    "propertyplantandequipmentgross": 446000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 313000,
    "accruedresearchanddevelopmentexpensecurrent": 802000,
    "employeerelatedliabilitiescurrent": 1315000,
    "restructuringreservecurrent": 258000,
    "accruedprofessionalfeescurrent": 415000,
    "otheraccruedliabilitiescurrent": 39000,
    "accruedinterestondebt": 57000,
    "operatingleasecost": 600000,
    "operatingleaseweightedaverageincrementalborrowingrate": 0.08,
    "operatingleaseweightedaverageremainingleaseterm1": 0.86,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 404000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 32000,
    "lesseeoperatingleaseliabilitypaymentsdue": 436000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 14000,
    "operatingleaseliability": 422000,
    "longtermdebt": 10715000,
    "longtermdebtpercentagebearingvariableinterestrate": 0.0575,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 4.31,
    "debtinstrumentcarryingamount": 11213000,
    "debtinstrumentunamortizeddiscount": 498000,
    "interestexpensedebt": 1300000,
    "debtinstrumentinterestrateeffectivepercentage": 0.1085,
    "longtermdebtmaturitiesfinalfeedue": -900000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 5398000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 5398000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 417000,
    "aggregateamountofmilestonepayment": 100000,
    "royaltypaymentpercentageonnetsales": 0.03,
    "maximumrepaymentpercentageofgrantsreceivedfromofficeofchiefscientist": 1,
    "contingentliabilityrelatedtograntsreceivedroyaltiespayableincludingaccruedliborinterest": 2700000,
    "relatedpartytransactionpercentageofexpenses": 0.05,
    "classofwarrantorrightoutstanding": 323892,
    "classofwarrantorrightforfeited": 2,
    "classofwarrantorrightexercisable": 323892,
    "classofwarrantorrightforfeitedinperiodweightedaverageexerciseprice": 520,
    "classofwarrantorrightexercisableinperiodweightedaverageexerciseprice": 4.31,
    "classofwarrantorrightexpirationperiod": "P2Y8M26D",
    "classofwarrantorrightexercisableexpirationperiod": "P2Y8M26D",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodcontractuallife": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexercisableperiodofvestedoptions": "three months",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 7600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 3.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.29,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 1400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 10.16,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 4.08,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 9.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 13.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y3M14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0036,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0163,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionscontractualterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 349725,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 147243,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 266977,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 4.67,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 10.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 8.65,
    "allocatedsharebasedcompensationexpense": 8666000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -18582000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -15995000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -34577000,
    "deferredtaxassetsvaluationallowance": 52584000,
    "valuationallowancedeferredtaxassetchangeinamount": 5900000,
    "operatinglosscarryforwards": 86900000,
    "netoperatinglosscarryforwardexpirationyear": 2037,
    "netoperatinglosscarryforwardseligibletooffsettaxableincomemaximum": 0.8,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 3600000,
    "federalresearchcreditscarryforwardsexpirationyear": 2040,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "deferredtaxassetsoperatinglosscarryforwards": 43759000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2200000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 431000,
    "deferredtaxassetstaxcreditcarryforwards": 3624000,
    "deferredtaxassetsinprocessresearchanddevelopment": 2511000,
    "deferredtaxassetsoperatingleaserightofuseassets": 98000,
    "deferredtaxassetsoperatingleaseliabilities": 98000,
    "deferredtaxassetsother": 59000,
    "deferredtaxassetsgross": 52584000,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.01,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.02,
    "effectiveincometaxratereconciliationtaxcredits": 0.028999999999999998,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": 0.009000000000000001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.23800000000000002,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "interestandotherincome": 337000,
    "foreigncurrencytransactiongainlossbeforetax": -35000,
    "investmentincomenet": -15000,
    "interestexpenseother": 1409000,
    "numberofoperatingsegments": 1,
    "numberofgeographicregions": 2,
    "cashandcashequivalentsfairvaluedisclosure": 24668000,
    "cashandcashequivalentandavailableforsaledebtsecuritiesamortizedcost": 24668000,
    "restructuringreserve": 258000,
    "restructuringcharges": 1894000,
    "paymentsforrestructuring": 1636000
  },
  {
    "date": "2019-12-30",
    "symbol": "ELOX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ELOX",
    "entityregistrantname": "ELOXX PHARMACEUTICALS, INC.",
    "entitycentralindexkey": 1035354,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "001-31326",
    "entitytaxidentificationnumber": "84-1368850",
    "entityaddressaddressline1": "950 Winter Street",
    "entityaddresscityortown": "Waltham",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2451,
    "cityareacode": 781,
    "localphonenumber": "577-5300",
    "entityshellcompany": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityincorporationstatecountrycode": "DE",
    "security12btitle": "Common Stock, $0.01 par value",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "cashandcashequivalentsatcarryingvalue": 22493000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 33783000,
    "restrictedcashcurrent": 43000,
    "prepaidexpenseandotherassetscurrent": 1390000,
    "assetscurrent": 57709000,
    "propertyplantandequipmentnet": 201000,
    "operatingleaserightofuseasset": 924000,
    "otherassetsnoncurrent": 113000,
    "assets": 58947000,
    "accountspayablecurrent": 1871000,
    "accruedliabilitiescurrent": 142000,
    "longtermdebtcurrent": 4336000,
    "duetoaffiliatecurrent": 403000,
    "operatingleaseliabilitycurrent": 499000,
    "taxespayablecurrent": 43000,
    "liabilitiescurrent": 11807000,
    "longtermdebtnoncurrent": 10502000,
    "operatingleaseliabilitynoncurrent": 425000,
    "liabilities": 22734000,
    "commonstockvalue": 402000,
    "treasurystockcommonvalue": 1703000,
    "additionalpaidincapitalcommonstock": 174515000,
    "accumulatedothercomprehensiveincomelossnetoftax": 18000,
    "retainedearningsaccumulateddeficit": -137019000,
    "stockholdersequity": -137019000,
    "liabilitiesandstockholdersequity": 58947000,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 500000000,
    "commonstocksharesissued": 40186469,
    "commonstocksharesoutstanding": -155706,
    "treasurystockcommonshares": 155706,
    "researchanddevelopmentexpense": 200000,
    "generalandadministrativeexpense": 24713000,
    "operatingexpenses": 50555000,
    "operatingincomeloss": -50555000,
    "othernonoperatingincomeexpense": -319000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -50874000,
    "netincomeloss": -50874000,
    "netincomelossavailabletocommonstockholdersbasicanddiluted": -50874000,
    "earningspersharebasicanddiluted": -1.34,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 38063173,
    "othercomprehensiveincomeavailableforsalesecuritiesadjustmentnetoftaxportionattributabletoparent": 18000,
    "comprehensiveincomenetoftax": -50856000,
    "stockissuedduringperiodvaluenewissues": 32172000,
    "stockissuedduringperiodsharesnewissues": 35362,
    "stockissuedduringperiodvaluestockoptionsexercised": 169000,
    "stockissuedduringperiodsharesstockoptionsexercised": 116327,
    "stockissuedduringperiodvaluewarrantsexercised": -179000,
    "stockissuedduringperiodshareswarrantsexercised": -14893,
    "stockissuedduringperiodvaluenewissuesincludingfinancecosts": 455000,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 421000,
    "restrictedstockvestedduringperiodvalue": -395000,
    "restrictedstockvestedduringperiodshares": -49390,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 11336000,
    "profitloss": -50874000,
    "sharebasedcompensation": 11336000,
    "depreciation": 87000,
    "gainlossonsaleofpropertyplantequipment": 2000,
    "operatingleaserightofuseassetamortization": 472000,
    "amortizationofdebtdiscountpremium": 535000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 301000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -83000,
    "increasedecreaseinaccountspayable": 1124000,
    "increasedecreaseinaccruedliabilities": -1300000,
    "increasedecreaseinoperatingleaseliabilities": -472000,
    "increasedecreaseinaccruedtaxespayable": -79000,
    "netcashprovidedbyusedinoperatingactivities": -39391000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 67214000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 33750000,
    "paymentstoacquirepropertyplantandequipment": 40000,
    "proceedsfromsaleofpropertyplantandequipment": 2000,
    "paymentstoacquirelongterminvestments": 22000,
    "netcashprovidedbyusedininvestingactivities": -33524000,
    "proceedsfromissuanceofcommonstock": 710000,
    "proceedsfromissuanceoflongtermdebt": 15000000,
    "paymentsofdebtissuancecosts": 276000,
    "proceedsfromstockoptionsexercised": 169000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 1378000,
    "proceedsfromadvancesfromcollaborationpartners": 403000,
    "netcashprovidedbyusedinfinancingactivities": 46800000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -26115000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 22536000,
    "restrictedcashandcashequivalents": 43000,
    "interestpaidnet": 986000,
    "incometaxespaidnet": 36000,
    "noncashissuanceofsharesuponexerciseofwarrants": 179000,
    "fairvalueofwarrantsissuedinconnectionwithlongtermdebt": 421000,
    "remeasurementofoperatingleases": 176000,
    "numberofrareandultrararediseaseduetoprematurestoppageofcodons": 1800,
    "cashandcashequivalentandavailableforsaledebtsecurities": 56276000,
    "cashandcashequivalentsfairvaluedisclosure": 22493000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 33765000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 19000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1000,
    "availableforsalesecuritiesdebtsecurities": 33783000,
    "cashandcashequivalentandavailableforsaledebtsecuritiesamortizedcost": 56258000,
    "cashandcashequivalentandavailableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 19000,
    "cashandcashequivalentandavailableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1000,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentusefullifedescription": "Over the shorter of the expected lease term or estimated useful life",
    "prepaidresearchanddevelopmentcurrent": 448000,
    "otherprepaidexpensecurrent": 699000,
    "prepaidinsurance": 217000,
    "contractreceivablecurrent": 26000,
    "propertyplantandequipmentgross": 488000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 287000,
    "accruedresearchanddevelopmentexpensecurrent": 1560000,
    "employeerelatedliabilitiescurrent": 2200000,
    "accruedprofessionalfeescurrent": 664000,
    "otheraccruedliabilitiescurrent": 137000,
    "accruedinterestondebt": 94000,
    "operatingleasecost": 500000,
    "operatingleaseestimatedincrementalborrowingsrate": 0.08,
    "operatingleasepresentvalueatinception": 1500000,
    "operatingleaseliability": 924000,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y9M21D",
    "operatingleasepayments": 500000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 556000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 404000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 32000,
    "lesseeoperatingleaseliabilitypaymentsdue": 992000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 68000,
    "longtermdebt": 13938000,
    "longtermdebtpercentagebearingvariableinterestrate": 0.0725,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 4.32,
    "debtinstrumentcarryingamount": 15000000,
    "deferredfinancecostsnet": 1100000,
    "interestexpensedebt": 1600000,
    "debtinstrumentinterestrateeffectivepercentage": 0.124,
    "longtermdebtmaturitiesfinalfeedue": -900000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 4583000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 5000000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 5000000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 417000,
    "debtinstrumentunamortizeddiscount": 1062000,
    "aggregateamountofmilestonepayment": 6100000,
    "collaborativearrangementadditionalconsiderationreceivableaspercentageofallnonrefundablenoncontingentconsideration": 0.03,
    "collaborativearrangementadditionalconsiderationreceivableaspercentageofnonrefundablenoncontingentconsiderationreceived": 0.03,
    "royaltypaymentpercentageonnetsales": 0.03,
    "maximumrepaymentpercentageofgrantsreceivedfromofficeofchiefscientist": 1,
    "contingentliabilityrelatedtograntsreceivedroyaltiespayableincludingaccruedliborinterest": 2700000,
    "classofwarrantorrightexercised": 59707,
    "classofwarrantorrightoutstanding": 323894,
    "classofwarrantorrightissued": 40834,
    "classofwarrantorrightforfeited": 4474,
    "classofwarrantorrightexercisable": 323894,
    "classofwarrantorrightexercisableinperiodweightedaverageexerciseprice": 4.32,
    "classofwarrantorrightexpirationperiod": "P3Y8M26D",
    "classofwarrantorrightexercisableexpirationperiod": "P3Y8M26D",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodcontractuallife": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexercisableperiodofvestedoptions": "P3M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1842990,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 9.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 100000,
    "allocatedsharebasedcompensationexpense": 11336000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Subject to continued service through the vesting date, one-third of the Time-Vesting Awards will vest and become immediately exercisable on the first anniversary of the effective date, with an additional one-twelfth of the Time-Vesting Awards vesting on each quarterly anniversary of the effective date",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.0033,
    "sharebasedcompensationarrangementbysharebasedpaymentawardvestingrightsquarterlypercentage": 0.00083,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 18400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y3M7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.28,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 4000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 4737670,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 250712,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1785477,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 11.17,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 4.27,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 10.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 11.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y6M14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y6M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 3629073,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 2498968,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0151,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0262,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionscontractualterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 463945,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 190202,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 9.45,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 11.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 8.09,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -22242000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -28632000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -50874000,
    "deferredtaxassetsvaluationallowance": 46682000,
    "valuationallowancedeferredtaxassetchangeinamount": 10800000,
    "operatinglosscarryforwards": 73700000,
    "netoperatinglosscarryforwardexpirationyear": 2037,
    "netoperatinglosscarryforwardseligibletooffsettaxableincomemaximum": 0.8,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 3000000,
    "federalresearchcreditscarryforwardsexpirationyear": 2037,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "deferredtaxassetsoperatinglosscarryforwards": 38357000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2801000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 615000,
    "deferredtaxassetstaxcreditcarryforwards": 2980000,
    "deferredtaxassetsinprocessresearchanddevelopment": 1831000,
    "deferredtaxassetsoperatingleaserightofuseassets": 169000,
    "deferredtaxassetsoperatingleaseliabilities": 169000,
    "deferredtaxassetsother": 98000,
    "deferredtaxassetsgross": 46682000,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.009,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.015,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": 0.011,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.215,
    "preferredstockdividendratepercentage": 0.08,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5525509,
    "interestandotherincome": 1072000,
    "foreigncurrencytransactiongainlossbeforetax": -76000,
    "investmentincomenet": 301000,
    "interestexpenseother": 1616000,
    "numberofoperatingsegments": 1,
    "numberofgeographicregions": 2
  },
  {
    "date": "2018-12-30",
    "symbol": "ELOX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2018-12-31",
    "documentfiscalyearfocus": 2018,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ELOX",
    "entityregistrantname": "ELOXX PHARMACEUTICALS, INC.",
    "entitycentralindexkey": 1035354,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "No",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated Filer",
    "entitycommonstocksharesoutstanding": 35860114,
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitysmallbusiness": "true",
    "cashandcashequivalentsatcarryingvalue": 48606000,
    "restrictedcashcurrent": 45000,
    "prepaidexpenseandotherassetscurrent": 1690000,
    "assetscurrent": 50341000,
    "propertyplantandequipmentnet": 248000,
    "otherassetsnoncurrent": 129000,
    "assets": 50718000,
    "accountspayablecurrent": 747000,
    "accruedliabilitiescurrent": 25000,
    "taxespayablecurrent": 122000,
    "liabilitiescurrent": 7807000,
    "commonstockvalue": 360000,
    "additionalpaidincapitalcommonstock": 129825000,
    "treasurystockcommonvalue": 1129000,
    "retainedearningsaccumulateddeficit": -86145000,
    "stockholdersequity": -86145000,
    "liabilitiesandstockholdersequity": 50718000,
    "preferredstockparorstatedvaluepershare": 0.01,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.01,
    "commonstocksharesauthorized": 500000000,
    "commonstocksharesissued": 35951537,
    "commonstocksharesoutstanding": -91423,
    "treasurystockcommonshares": 91423,
    "researchanddevelopmentexpense": 100000,
    "generalandadministrativeexpense": 26482000,
    "businesscombinationacquisitionrelatedcostsandadjustmenttoestimateonaccruedexpense": 594000,
    "operatingexpenses": 47565000,
    "operatingincomeloss": -47565000,
    "othernonoperatingincomeexpense": 502000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -47063000,
    "incometaxexpensebenefit": 122000,
    "netincomeloss": -47185000,
    "netincomelossavailabletocommonstockholdersbasicanddiluted": -47185000,
    "earningspersharebasicanddiluted": -1.45,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 32436506,
    "stockissuedduringperiodvaluenewissues": 53573000,
    "stockissuedduringperiodsharesnewissues": 201100,
    "stockissuedduringperiodvaluestockoptionsexercised": 446000,
    "stockissuedduringperiodsharesstockoptionsexercised": 1334522,
    "stockissuedduringperiodvalueissuedforservices": -6000,
    "stockissuedduringperiodsharesissuedforservices": 569395,
    "stockissuedduringperiodvaluewarrantsexercised": -52000,
    "stockissuedduringperiodshareswarrantsexercised": -3385,
    "stockissuedduringperiodvaluenewissuesincludingfinancecosts": 2423000,
    "treasurystockvalueacquiredcostmethod": 31000,
    "treasurystocksharesacquired": 5000,
    "restrictedstockvestedduringperiodvalue": -1046000,
    "restrictedstockvestedduringperiodshares": -83038,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationandexerciseofstockoptions": 13370000,
    "profitloss": -47185000,
    "sharebasedcompensation": 13370000,
    "depreciation": 216000,
    "gainlossonsaleofpropertyplantequipment": -12000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1080000,
    "increasedecreaseinothernoncurrentassets": 41000,
    "increasedecreaseinaccountspayable": -780000,
    "increasedecreaseinaccruedliabilities": 3999000,
    "increasedecreaseinaccruedtaxespayable": 122000,
    "netcashprovidedbyusedinoperatingactivities": -31367000,
    "paymentstoacquirepropertyplantandequipment": 235000,
    "proceedsfromsaleofpropertyplantandequipment": 6000,
    "paymentstoacquirelongterminvestments": 88000,
    "netcashprovidedbyusedininvestingactivities": -317000,
    "proceedsfromissuanceofcommonstock": 2165000,
    "proceedsfromstockoptionsexercised": 446000,
    "netcashprovidedbyusedinfinancingactivities": 56184000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 24500000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 48651000,
    "restrictedcashandcashequivalents": 45000,
    "noncashacquisitionoftreasuryshares": 1129000,
    "noncashacquisitionofsharesfromequitysalesagreement": 255000,
    "numberofrareandultrararediseaseduetoprematurestoppageofcodons": 1800,
    "numberofnovelersgdrugcandidates": 170,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentusefullifedescription": "Over the shorter of the expected lease term or estimated useful life",
    "professionalfees": 600000,
    "prepaidinsurance": 251000,
    "contractreceivablecurrent": 20000,
    "prepaidresearchanddevelopmentcurrent": 864000,
    "otherprepaidexpensecurrent": 555000,
    "propertyplantandequipmentgross": 452000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 204000,
    "employeerelatedliabilitiescurrent": 2562000,
    "accruedresearchanddevelopmentexpensecurrent": 3086000,
    "accruedprofessionalfeescurrent": 985000,
    "otheraccruedliabilitiescurrent": 305000,
    "debtinstrumentconvertibletermsofconversionfeature": "According to the Agreement, the outstanding portion of the Convertible Loan (without accrued interest) automatically converts upon the consummation of an equity investment by a third party of an aggregate amount of at least $5.0 million (the “Qualified Equity Investment”), prior to the date that is two years from the Closing Date (the “Maturity Date”), into equity securities of the same class issued by the Company in such Qualified Equity Investment.",
    "aggregateamountofmilestonepayment": 6100000,
    "collaborativearrangementadditionalconsiderationreceivableaspercentageofallnonrefundablenoncontingentconsideration": 0.03,
    "collaborativearrangementadditionalconsiderationreceivableaspercentageofnonrefundablenoncontingentconsiderationreceived": 0.03,
    "lesseeoperatingleasetermofcontract": "P3Y",
    "leaseexpirationdate1": "2020-04-30",
    "lesseeoperatingleaserenewalterm": "P2Y",
    "operatingleaseexpense": 100000,
    "leaseandrentalexpense": 400000,
    "proceedsfromresearchanddevelopmentgrants": 2600000,
    "royaltypaymentpercentageonnetsales": 0.03,
    "maximumrepaymentpercentageofgrantsreceivedfromofficeofchiefscientist": 1,
    "contingentliabilityrelatedtograntsreceivedroyaltiespayableincludingaccruedliborinterest": 2700000,
    "operatingleasesfutureminimumpaymentsduecurrent": 541000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 490000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 310000,
    "operatingleasesfutureminimumpaymentsdue": 1341000,
    "aggregateofferingprice": 47500000,
    "classofwarrantorrightexercised": 64374,
    "classofwarrantorrightoutstanding": 347241,
    "classofwarrantorrightforfeited": 68434,
    "classofwarrantorrightexercisable": 347241,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 3.77,
    "classofwarrantorrightexercisedinperiodweightedaverageexerciseprice": 0.8,
    "classofwarrantorrightforfeitedinperiodweightedaverageexerciseprice": 8,
    "classofwarrantorrightexercisableinperiodweightedaverageexerciseprice": 3.77,
    "classofwarrantorrightexpirationperiod": "P3Y11M1D",
    "classofwarrantorrightexercisableexpirationperiod": "P3Y11M1D",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodcontractuallife": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexercisableperiodofvestedoptions": "P3M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1711881,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 18.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 349241,
    "allocatedsharebasedcompensationexpense": 13370000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Subject to continued service through the vesting date, 1/3 of the Time-Vesting Awards will vest and become immediately exercisable on the first anniversary of the effective date, with an additional 1/12 of the Time-Vesting Awards vesting on each quarterly anniversary of the effective date",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 18700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y6M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 18.06,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 8300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3261719,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 331301,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1019835,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 13.09,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.34,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 9.66,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 11.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y6M21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 11650373,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 6598055,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.903,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0255,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.032,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardforfeiturerate": 0.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 2.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 554147,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 354985,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 103321,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 9.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 18.36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 14.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 14.95,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -24439000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -22624000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -47063000,
    "currentfederaltaxexpensebenefit": 94000,
    "currentstateandlocaltaxexpensebenefit": 28000,
    "deferredtaxassetsoperatinglosscarryforwards": 29521000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1001000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 377000,
    "deferredtaxassetstaxcreditcarryforwards": 714000,
    "deferredtaxassetsinprocessresearchanddevelopment": 4216000,
    "deferredtaxassetsother": 40000,
    "deferredtaxassetsgross": 35869000,
    "deferredtaxassetsvaluationallowance": 35869000,
    "valuationallowancedeferredtaxassetchangeinamount": 7700000,
    "operatinglosscarryforwards": 34600000,
    "netoperatinglosscarryforwardexpirationyear": 2037,
    "netoperatinglosscarryforwardseligibletooffsettaxableincomemaximum": 0.8,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 700000,
    "federalresearchcreditscarryforwardsexpirationyear": 2037,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.024,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.03,
    "effectiveincometaxratereconciliationadjustmentstodeferredtaxes": -0.018,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": 0.008,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.001,
    "effectiveincometaxratereconciliationtaxcutsandjobsactchangeinvaluationallowancepercent": -0.001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.195,
    "effectiveincometaxratereconciliationotheradjustments": -0.002,
    "effectiveincometaxratecontinuingoperations": -0.003,
    "preferredstockdividendratepercentage": 0.08,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 4163107,
    "interestandotherincome": 601000,
    "foreigncurrencytransactiongainlossbeforetax": -92000,
    "interestexpenseother": 7000,
    "numberofoperatingsegments": 1,
    "numberofgeographicregions": 2
  }
]